All data are based on the daily closing price as of July 1, 2025
k

KOBAYASHI Pharmaceutical

4967.TSE
37.05 USD
-0.38
-1.02%

Overview

Last close
37.05 usd
Market cap
2.75B usd
52 week high
45.14 usd
52 week low
31.67 usd
Target price
38.94 usd

Valuation

P/E
37.0651
Forward P/E
N/A
Price/Sales
2.4533
Price/Book Value
1.9363
Enterprise Value
2.34B usd
EV/Revenue
2.0679
EV/EBITDA
23.7194

Key financials

Revenue TTM
1.13B usd
Gross Profit TTM
582.93M usd
EBITDA TTM
214.94M usd
Earnings per Share
1.01 usd
Dividend
0.71 usd
Total assets
1.69B usd
Net debt
-346.21M usd

About

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese medicine; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air freshener, lens cleaner, cooling gel sheets, and oral hygiene products. It also manufactures and sells pharmaceuticals, cosmetics, and health foods; and manufactures and sells synthetic resin products; markets nutritional supplements and skin care products through mail orders; and sells skincare products, daily necessities, and health foods, as well as manufactures body warmers. In addition, the company engages in transportation, real estate management, and advertising planning and production businesses; manufacture of sanitary and paper products; and asset management. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.
  • Symbol
    4967.TSE
  • Exchange
    TSE
  • Isin
    JP3301100008
  • Country
    Japan
  • Sector
    Consumer Defensive
  • Industry
    Household & Personal Products
  • CEO
    Mr. Kazumasa Kobayashi
  • Headquarter
    Osaka
  • Web site
    https://www.kobayashi.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top